Minimally Invasive Total Knee Arthroplasty for Osteoarthritis
Seth S. Leopold, M.D.
2009
N Engl J Med 2009; 360:1749-1758
Open
Hybrid Strategy to Prevent Venous Thromboembolism after Joint Arthroplasty
David Garcia, M.D.
2018
N Engl J Med 2018; 378:762-763
Open
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis List of authors.
Harry R. Büller, M.D., Claudette Bethune, Ph.D., Sanjay Bhanot, M.D., Ph.D., David Gailani, M.D., et al., for the FXI-ASO TKA Investigators*
2015
N Engl J Med 2015; 372:232-240
Open
Differences between Men and Women in the Rate of Use of Hip and Knee Arthroplasty
Gillian A. Hawker, M.D., James G. Wright, M.D., M.P.H., Peter C. Coyte, Ph.D., J. Ivan Williams, Ph.D., et al.
2000
N Engl J Med 2000; 342:1016-1022
Open
Racial, Ethnic, and Geographic Disparities in Rates of Knee Arthroplasty among Medicare Patients
Jonathan Skinner, Ph.D., James N. Weinstein, D.O., Scott M. Sporer, M.D., and John E. Wennberg, M.D., M.P.H.
2003
N Engl J Med 2003; 349:1350-1359
Open
Racial, Ethnic, and Geographic Disparities in Rates of Knee Arthroplasty
2004
N Engl J Med 2004; 350:305-306
Open
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Michael R. Lassen, M.D., Walter Ageno, M.D., Lars C. Borris, M.D., Jay R. Lieberman, M.D., et al.
2008
N Engl J Med 2008; 358:2776-2786
Open
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty
David R. Anderson, M.D., Michael Dunbar, M.D., John Murnaghan, M.D., Susan R. Kahn, M.D., et al.
2018
N Engl J Med 2018; 378:699-707
Open
Minimally Invasive Total Knee Arthroplasty
2009
N Engl J Med 2009; 361:633-634
Open
Venous Thromboembolism Prophylaxis after Hip or Knee Arthroplasty
2018
N Engl J Med 2018; 378:1848-1849
Open
Rehabilitation After Hip and Knee Arthroplasty—Reply
Michael C. Munin, MD; Thomas E. Rudy, PhD; Nancy W. Glynn, PhD; et al
1998
JAMA. 1998;280(16):1402-1403.
Open
Rehabilitation After Hip and Knee Arthroplasty
Aaron M. Levine, MD
1998
JAMA. 1998;280(16):1402-1403.
Open
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al
1998
Arch Intern Med. 1998;158(14):1525-1531.
Open
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al
1998
Arch Intern Med. 1998;158(14):1525-1531.
Open
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
Richard H. White, MD; Patrick S. Romano, MD, MPH; Hong Zhou, PhD; et al
1998
Arch Intern Med. 1998;158(14):1525-1531.
Open
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin
Jacques R. Leclerc, MD; Michael Gent, DSc; Jack Hirsh, MD; et al
1998
Arch Intern Med. 1998;158(8):873-878.
Open
Early Inpatient Rehabilitation After Elective Hip and Knee Arthroplasty
Michael C. Munin, MD; Thomas E. Rudy, PhD; Nancy W. Glynn, PhD; et al
1998
JAMA. 1998;279(11):847-852.
Open
Subcutaneous Low-Molecular-Weight Heparin vs Warfarin for Prophylaxis of Deep Vein Thrombosis After Hip or Knee Implantation
Russell D. Hull, MBBS, MSc; Gary E. Raskob, MSc; Graham F. Pineo, MD; et al
1997
Arch Intern Med. 1997;157(3):298-303.
Open
The Effect of Age on Pain, Function, and Quality of Life After Total Hip and Knee Arthroplasty
C. Allyson Jones, PhD; Donald C. Voaklander, PhD; D. William C. Johnston, MD; et al
2001
Arch Intern Med. 2001;161(3):454-460.
Open
Postthrombotic Syndrome After Hip or Knee Arthroplasty
Jeffrey S. Ginsberg, MD; M. Gent, DSc; F. Turkstra, MD; et al
2000
Arch Intern Med. 2000;160(5):669-672.
Open
A 57-Year-Old Man With Osteoarthritis of the Knee
Jess H. Lonner, MD, Discussant
2003
JAMA. 2003;289(8):1016-1025.
Open
A 57-Year-Old Man With Osteoarthritis of the Knee
Jess H. Lonner, MD, Discussant
2003
AMA. 2003;289(8):1016-1025.
Open
The Potential Role of Fondaparinux as Venous Thromboembolism Prophylaxis After Total Hip or Knee Replacement or Hip Fracture Surgery
John A. Heit, MD
2002
Arch Intern Med. 2002;162(16):1806-1808.
Open
Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement
James D. Douketis, MD, FRCPC; John W. Eikelboom, MBBS, MSc, FRACP; Daniel J. Quinlan, MBBS; et alAndrew R. Willan, PhD; Mark A. Crowther, MD, MSc, FRCPC
2002
Arch Intern Med. 2002;162(13):1465-1471.
Open
Comparison of the Oral Direct Thrombin Inhibitor Ximelagatran With Enoxaparin as Prophylaxis Against Venous Thromboembolism After Total Knee Replacement
John A. Heit, MD; Clifford W. Colwell, MD; Charles W. Francis, MD; et al
2001
Arch Intern Med. 2001;161(18):2215-2221.
Open